Development of a nitric oxide-releasing antiviral GEL for the treatment of cervical HPV infections and prevention of downstream malignancies in women
Ended Project Grant Awarded Last action
- Award ID
- R44AI143022
- Recipient
-
Novan Inc. UEI JVY7LPMCSFM8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $943,482
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Funding
-
- $817,112.00 Federal
- $126,370.00 Non-federal
- Place of performance
- Morrisville, NC, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$1 | $0 | |
| Amendment | -$529,802 | $0 | |
| Amendment | -$126,370 | $0 | |
| Amendment | $1 | $0 | |
| Amendment | $110,781 | $0 | |
| Amendment | -$110,781 | $0 | |
| Amendment | -$110,781 | $0 | |
| Amendment | $110,781 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $110,781 | $0 | |
| Amendment | -$110,781 | $0 | |
| Amendment | -$110,781 | -$110,781 | |
| Amendment | $110,781 | $110,781 | |
| Amendment | $126,370 | $0 | |
| Amendment | $126,370 | $126,370 | |
| Amendment | $997,413 | $0 | |
| Original award | $223,131 | $0 |
Show all 20
Quick answers
Who received award R44AI143022?
R44AI143022 was awarded to Novan Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 1, 2019.
How much is award R44AI143022 worth?
$943,482 has been obligated on R44AI143022: $817,112 in federal funding and $126,370 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award